clinion

Insights / Awards

Clinion Wins the IRT Startup Innovation Award

Clinion Wins the IRT Startup Innovation Award

Clinion proudly celebrates its recognition as the winner of the IRT Startup Innovation Award, a distinction honoring exceptional achievements in interactive response technology (IRT). Our CEO, Manuj Vangipurapu, accepted the accolade at the IRT Awards ceremony hosted by Informa Connect Life Sciences in Boston, Massachusetts.

Manuj has spearheaded the development of transformative RTSM technology that merges directly with electronic data capture systems. This integration streamlines workflows, removes duplicate processes, and shortens trial durations, creating unprecedented efficiency standards across clinical research operations.

 

Why Clinion Stands Out

EDC-Integrated Randomization

Subject randomization occurs natively within the Clinion EDC environment, removing the complexity of juggling multiple platforms. The system accommodates various methodologies, including block-based, stratified, and adaptive approaches, while supporting every blinding level from open-label through triple-blind configurations, all tailored to specific protocol needs.


Easy to Use

Clinion RTSM Software is built for simplicity. Its intuitive interface shortens training time and makes daily tasks straightforward for site teams. Clear navigation, automated checks, and a unified workflow reduce operational burden and help staff stay focused on execution rather than system handling.


Flexible and Scalable

Our solution supports studies of any scale or complexity. It can be deployed on its own or as part of Clinion’s broader platform, giving sponsors and CROs the freedom to configure and expand as needs evolve without added effort or cost.

The Clinion Advantage

Fewer randomization errors

0 %

Stronger protocol compliance

0 %

Less inventory waste

0 %

Why This Matters

This recognition affirms Clinion’s role as a catalyst for change in clinical trial technology. The platform’s integrated approach enables research teams to execute studies with enhanced speed, precision, and reliability. It sets a new standard for innovation and operational excellence in clinical research.

Unlock the Future of Clinical Trials with Clinion.

Cut your trial costs by 35% and accelerate your time-to-market by 30%

Compliance

Fully Compliant with Global Standards

FDA,HIPAA and ISO Logos
ich ,gdpr ,eu compliant logos
Clinion’s adherence to global regulatory standards including FDA 21 CFR Part 11, HIPAA, ISO 9001:2015, ISO 27001:2013, ICH, GDPR, and EU Annex 11.